Skip to content
Safety ProfileEvidence-Based

Angiotensin-(1-7) Side Effects

Honest, evidence-based safety analysis for Angiotensin-(1-7). Frequency data, severity classification, data limitations, and what we genuinely don't know.

Quick Answer

The main side effects of Angiotensin-(1-7) are related to its blood pressure-lowering effects, including hypotension, dizziness, and lightheadedness. Injection site reactions are also common with subcutaneous administration. Serious hypotension can occur in susceptible individuals. Due to limited data, long-term side effects are not well-defined.

Data Context: What We Actually Know

Important: data limitations

Safety data is primarily from early-phase clinical trials and preclinical studies. Long-term safety data is limited. The information provided is based on the best available evidence but should be interpreted cautiously, especially for chronic use.

Side Effects by Severity

MildModerateSevere / Serious
HypotensionMild

Frequency: Common

Monitor blood pressure closely, especially in patients with pre-existing hypotension or those taking antihypertensive medications.

Injection site reactionsMild

Frequency: Common

Redness, swelling, or pain at the injection site. Rotate injection sites and use proper sterile technique.

Dizziness or lightheadednessMild

Frequency: Common

Transient, usually related to blood pressure changes. Advise patients to rise slowly from sitting or lying positions.

Severe hypotensionSevere / Serious

Frequency: Rare

Requires immediate medical intervention. Occurs in susceptible individuals with impaired cardiovascular function.

FlushingMild

Frequency: Rare

Transient skin redness and warmth.

Contraindications

  • Hypotension
  • Severe aortic stenosis or hypertrophic obstructive cardiomyopathy
  • Concurrent use of multiple antihypertensive medications (use with caution)
  • Known hypersensitivity to Angiotensin-(1-7) or formulation components

Drug Interactions

No formal pharmacokinetic drug interaction studies have been conducted for most research peptides. The interactions below are theoretical, mechanism-based, or derived from limited case reports.
  • Antihypertensive medications (additive hypotensive effects)
  • Vasodilators (increased risk of hypotension)
  • NSAIDs (may attenuate vasodilatory effects)
  • ACE inhibitors and ARBs (potential synergistic or additive effects; monitor closely)

Frequently Asked Questions

What are the most common side effects of Angiotensin-(1-7)?
The most common side effects are hypotension, dizziness, lightheadedness, and injection site reactions. These are primarily related to its blood pressure-lowering effects.
Is Angiotensin-(1-7) safe to use with blood pressure medications?
Use with caution. Angiotensin-(1-7) can have additive hypotensive effects with other blood pressure medications, increasing the risk of hypotension. Monitor blood pressure closely.
Can Angiotensin-(1-7) cause serious side effects?
Severe hypotension is a potential serious side effect, particularly in individuals with pre-existing cardiovascular conditions or those taking multiple antihypertensive medications. This requires immediate medical intervention.
Are there any contraindications for Angiotensin-(1-7)?
Contraindications include pre-existing hypotension, severe aortic stenosis, hypertrophic obstructive cardiomyopathy, and known hypersensitivity to the peptide or its formulation components.
How should injection site reactions be managed?
Injection site reactions (redness, swelling, pain) are usually mild and can be managed by rotating injection sites and using proper sterile technique. If reactions are severe, consult a healthcare professional.

References

  1. 1
    Safety and tolerability of angiotensin-(1-7) in healthy volunteers(2010)PubMed ↗
  2. 2
    Effects of angiotensin-(1-7) on blood pressure and renal function(2006)PubMed ↗
  3. 3
    Angiotensin-(1-7): a novel therapeutic target for hypertension?(2009)PubMed ↗

Last updated: 2026-02-19